Skip to main content

Advertisement

Log in

Acute Renal Failure Associated with Gefitinib Therapy

  • Letter to the Editor
  • Published:
Lung Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Fukuoka M, Yano S, Giaccone G, et al. (2002) Final results from a phase II trial of ZD 1839 (‘Iressa’) for patients with advanced non-small-cell lung cancer (IDEAL 1). Proc Am Soc Clin Oncol 21:298a [abstr 1188]

    Google Scholar 

  2. Haringhuizen A, van Tinteren H, Vaessen H H, Baas P, van Zandwijk N (2004) Gefitinib as a last treatment option for non-small-cell lung cancer: durable disease control in a subset of patients. Ann Oncol 15:786–792

    Article  PubMed  CAS  Google Scholar 

  3. Inoune A, Saijo Y, Maemondo M, et al. (2003) Severe actue interstitial pneumonia and gefitinib. Lancet 361:137–139

    Article  Google Scholar 

  4. Kris MG, Natale RB, Herbst R, et al. (2002) A phase II trial of ZD 1839 (‘Iressa’) in advanced non-small-cell lung cancer (NSCLC) patients who had failed platinum- and docetaxel-based regimens (IDEAL 2). Proc Am Soc Clin Oncol 21: 292a [abstr 1166]

    Google Scholar 

  5. Kumasaka R, Nakamura N, Shirato K, et al. (2004) Side effects of the therapy: case 1. Nephrotic syndrome associated with gefitinib therapy. J Clin Oncol 22:2504–2505

    Article  PubMed  Google Scholar 

  6. Rossi A, Maione P, Gaizo FD, et al. (2005) Safety profile of gefitinib in advanced non-small-cell lung cancer elderly patients with chronic renal failure: two clinical cases. Lung Cancer 47:421–423

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Nai-Shun Yao.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wan, HL., Yao, NS. Acute Renal Failure Associated with Gefitinib Therapy. Lung 184, 249–250 (2006). https://doi.org/10.1007/s00408-005-2581-0

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00408-005-2581-0

Keywords

Navigation